AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PSTV
  4. [8-K] PLUS THERAPEUTICS, Inc. Reports Material Event

[8-K] PLUS THERAPEUTICS, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source:

Stock PSTV logo
Plus Therapeutics Inc

NASDAQ:PSTV

PSTV Rankings

#5324 Ranked by Market Cap
N/A Ranked by Dividends

PSTV Latest News

Aug 14, 2025
Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference
Jul 31, 2025
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic
Jul 23, 2025
Plus Therapeutics Announces $1.6 Million Advance Payment from CPRIT
Jul 15, 2025
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ� in Patients with Leptomeningeal Metastases
Jul 10, 2025
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference

PSTV Latest SEC Filings

Aug 13, 2025
[8-K] PLUS THERAPEUTICS, Inc. Reports Material Event
Aug 12, 2025
[8-K] PLUS THERAPEUTICS, Inc. Reports Material Event
Aug 12, 2025
[S-1] PLUS THERAPEUTICS, Inc. Files IPO Registration Statement
Jul 29, 2025
[SCHEDULE 13G/A] PLUS THERAPEUTICS, Inc. SEC Filing
Jul 25, 2025
[RW] PLUS THERAPEUTICS, Inc. SEC Filing

PSTV Stock Data

42.34M
59.46M
1.7%
2.1%
6.18%
Biotechnology
Surgical & Medical Instruments & Apparatus
United States
AUSTIN